New model uses blood tests to predict lung cancer prognosis
Lung cancer is a globally prevalent malignant tumor, with non-small cell lung cancer (NSCLC) being its predominant subtype. For patients with resectable NSCLC, surgical resection remains a cornerstone of curative-intent treatment.
Read original article on The Medical News →